A majority of the drugs used by the American government’s PEPFAR HIV treatment program in Africa are from India. Anything that stifles the Indian ability to produce affordable HIV drugs will also affect the American program to create an AIDS-free generation. They will have to rely on expensive patented drugs, which means treating fewer patients.

Leena Menghaney, representative of Doctors Without Borders in India, quoted in The Washington Post’s coverage of the ambitious free-trade agreement being negotiated between India and the European Union that could severely curtail India’s production and export of affordable drugs for millions living with HIV in developing countries.

For more coverage on the negotiations in India click here.

85 notes

Show

  1. the-bookworm-chronicles reblogged this from doctorswithoutborders
  2. jessemaximus reblogged this from doctorswithoutborders
  3. demonafternoon-blog-blog reblogged this from doctorswithoutborders
  4. yasmeenscurio-blog reblogged this from doctorswithoutborders
  5. thatsfabdoctor reblogged this from doctorswithoutborders
  6. mynameis-kellaanne reblogged this from doctorswithoutborders
  7. sunapeeblues reblogged this from doctorswithoutborders
  8. doctorswithoutborders posted this